Revolution Medicines (NASDAQ:RVMD – Get Free Report) will likely be releasing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Revolution Medicines to post earnings of ($2.35) per share and revenue of $25.58 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings overview page for the […]